Stock Scorecard
Stock Summary for LifeStance Health Group Inc (LFST) - $7.40 as of 1/9/2026 8:01:53 PM EST
Total Score
6 out of 30
Safety Score
27 out of 100
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for LFST
| Positive Quarterly and Annual earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the Annual earnings growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for LFST
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for LFST
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for LFST
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for LFST (27 out of 100)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 3 |
| Stock Price Trend (Max of 10) | 9 |
| Book Value (Max of 10) | 3 |
| Book Value to Price (Max of 10) | 0 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 3 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 1 |
| Trading Volume (Max of 10) | 9 |
| Price to Earnings (Max of 10) | 0 |
| Geopolitical Risk Adjustment (Always 0 for USA or a Negative Number for Non-USA) | -10 |
Latest News for for LFST
Financial Details for LFST
Company Overview |
|
|---|---|
| Ticker | LFST |
| Company Name | LifeStance Health Group Inc |
| Country | N/A |
| Description | LifeStance Health Group, Inc. (LFST) is a prominent provider of outpatient mental health services headquartered in Scottsdale, Arizona. The company offers a diverse array of evidence-based therapeutic and psychiatric care tailored to meet the needs of children, adolescents, adults, and seniors. With its extensive network of licensed clinicians and a strong emphasis on accessibility and patient-centered care, LifeStance is well-positioned to capitalize on the increasing demand for mental health services in a world increasingly prioritizing mental wellness. The organization’s dedication to enhancing patient outcomes and advocating for mental health further highlights its strategic potential for sustained growth in the dynamic healthcare market. |
| Sector Name | HEALTHCARE |
| Industry Name | MEDICAL CARE FACILITIES |
| Most Recent Quarter | 9/30/2025 |
| Next Earnings Date | 2/26/2026 |
Stock Price History |
|
| Last Day Price | 7.40 |
| Price 4 Years Ago | 4.94 |
| Last Day Price Updated | 1/9/2026 8:01:53 PM EST |
| Last Day Volume | 1,647,458 |
| Average Daily Volume | 2,113,911 |
| 52-Week High | 8.29 |
| 52-Week Low | 3.74 |
| Last Price to 52 Week Low | 97.86% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 20.55 |
| Sector PE | 55.07 |
| 5-Year Average PE | 8.90 |
| Free Cash Flow Ratio | 14.23 |
| Industry Free Cash Flow Ratio | 76.17 |
| Sector Free Cash Flow Ratio | 32.93 |
| Current Ratio Most Recent Quarter | 1.58 |
| Total Cash Per Share | 0.52 |
| Book Value Per Share Most Recent Quarter | 3.84 |
| Price to Book Ratio | 1.81 |
| Industry Price to Book Ratio | 27.40 |
| Sector Price to Book Ratio | 37.07 |
| Price to Sales Ratio Twelve Trailing Months | 1.98 |
| Industry Price to Sales Ratio Twelve Trailing Months | 1.23 |
| Sector Price to Sales Ratio Twelve Trailing Months | 12.84 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 1 |
Share Statistics |
|
| Total Shares Outstanding | 389,000,000 |
| Market Capitalization | 2,878,600,000 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Previous Dividend Amount | 0.0000 |
| Current Dividend Amount | 0.0000 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 69.16% |
| Reported EPS 12 Trailing Months | -0.03 |
| Reported EPS Past Year | 0.06 |
| Reported EPS Prior Year | -0.15 |
| Net Income Twelve Trailing Months | -9,117,000 |
| Net Income Past Year | -57,443,000 |
| Net Income Prior Year | -186,262,000 |
| Quarterly Revenue Growth YOY | 16.30% |
| 5-Year Revenue Growth | 42.55% |
| Operating Margin Twelve Trailing Months | 2.02% |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 203,903,000 |
| Total Cash Past Year | 154,571,000 |
| Total Cash Prior Year | 78,824,000 |
| Net Cash Position Most Recent Quarter | -65,489,000 |
| Net Cash Position Past Year | -125,219,000 |
| Long Term Debt Past Year | 279,790,000 |
| Long Term Debt Prior Year | 280,285,000 |
| Total Debt Most Recent Quarter | 269,392,000 |
| Equity to Debt Ratio Past Year | 0.84 |
| Equity to Debt Ratio Most Recent Quarter | 0.85 |
| Total Stockholder Equity Past Year | 1,446,285,000 |
| Total Stockholder Equity Prior Year | 1,428,930,000 |
| Total Stockholder Equity Most Recent Quarter | 1,492,741,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | 119,392,000 |
| Free Cash Flow Per Share Twelve Trailing Months | 0.31 |
| Free Cash Flow Past Year | 85,694,000 |
| Free Cash Flow Prior Year | -57,404,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.22 |
| MACD Signal | 0.22 |
| 20-Day Bollinger Lower Band | 4.38 |
| 20-Day Bollinger Middle Band | 6.00 |
| 20-Day Bollinger Upper Band | 7.61 |
| Beta | 1.11 |
| RSI | 68.96 |
| 50-Day SMA | 6.06 |
| 150-Day SMA | 6.64 |
| 200-Day SMA | 0.00 |
System |
|
| Modified | 1/8/2026 2:32:50 AM EST |